|
Eine Ebene nach oben |
Gruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 3
2019
Nathan, Steven D.; Costabel, Ulrich; Albera, Carlo; Behr, Jürgen; Wuyts, Wim A.; Kirchgaessler, Klaus-Uwe; Stauffer, John L.; Morgenthien, Elizabeth; Chou, Willis; Limb, Susan L. und Noble, Paul W.
(2019):
Pirfenidone in patients with idiopathic pulmonary fibrosis and more advanced lung function impairment.
In: Respiratory Medicine, Bd. 153: S. 44-51
2017
Behr, Jürgen; Crestani, Bruno; Wells, Athol; Kirchgässler, Klaus und Albera, Carlo
(2017):
N-acetylcysteine for idiopathic pulmonary fibrosis: the door is still open-Authors' reply.
In: Lancet Respiratory Medicine, Bd. 5, Nr. 1, E3-E3
2016
Behr, Jürgen; Bendstrup, Elisabeth; Crestani, Bruno; Günther, Andreas; Olschewski, Horst; Sköld, C. Magnus; Wells, Athol; Wuyts, Wim; Koschel, Dirk; Kreuter, Michael; Wallaert, Benoit; Lin, Chin-Yu; Beck, Jürgen und Albera, Carlo
(2016):
Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: a randomised, double-blind, placebo-controlled, phase 2 trial.
In: Lancet Respiratory Medicine, Bd. 4, Nr. 6: S. 445-453